YWP
INMB icon

YorkBridge Wealth Partners’s INmune Bio INMB Stock Holding History

YorkBridge Wealth Partners’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$65.7K Hold
10,369
– – 0.02% 255
2022
Q3 		$64K Hold
10,369
– – 0.02% 272
2022
Q2 		$92K Hold
10,369
– – 0.02% 276
2022
Q1 		$87K Hold
10,369
– – 0.02% 283
2021
Q4 		$106K Hold
10,369
– – 0.02% 279
2021
Q3 		$201K Hold
10,369
– – 0.05% 256
2021
Q2 		$182K Buy
+10,369
New +$140K 0.05% 245

Other funds holding INMB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FA
Fermata Advisors Sonoma, California $495M AUM 20.19% 1-Year Est. Return

YorkBridge Wealth Partners's INMB Position: Q4 2022 in Review

YorkBridge Wealth Partners held its INmune Bio (INMB) position steady in Q4 2022 at 10,369 shares worth $65.7K. The position accounts for 0.02% of the portfolio, ranked #255.

YorkBridge Wealth Partners first reported a position in INMB in Q2 2021 and has held it in 7 quarters since. The position peaked at $201K in Q3 2021. 34 funds tracked by Wall St. Rank hold INMB as of Q4 2022.

  • YorkBridge Wealth Partners held 10,369 shares of INmune Bio worth $65.7K as of Q4 2022.
  • YorkBridge Wealth Partners left its INmune Bio share count unchanged in Q4 2022.
  • INmune Bio made up 0.02% of YorkBridge Wealth Partners's portfolio in Q4 2022, its #255 holding.
  • YorkBridge Wealth Partners first reported a position in INmune Bio in Q2 2021 and has held it in 7 quarters since.
  • YorkBridge Wealth Partners's INmune Bio position peaked at $201K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held INmune Bio as of Q4 2022.

Based on YorkBridge Wealth Partners's 13F filing for Q4 2022, filed 26 Jan 2023.